×
Jeśli w ciągu kilku sekund nie nastąpi przekierowanie, kliknij
tutaj
.
Wszystko
Grafika
Wiadomości
Wideo
Mapy
Zakupy
Książki
Narzędzia wyszukiwania
Szukaj w internecie
Szukaj w internecie
Tylko język polski
Najnowsze
Najnowsze
Ostatnia godzina
Ostatnie 24 godziny
Ostatni tydzień
Ostatni miesiąc
Ostatni rok
Archiwa
Według trafności
Według trafności
Według daty
WAT YTD Stock Return Of -5.7% Underperforms CRL by -3.0% and Underperforms BRKR by -17%
Trefis
Waters (WAT) returned -5.7% YTD; WAT underperformed Charles River Laboratories by -3.0% (CRL returned -2.8%). CRL LTM revenue changed 3.9% vs.
13 godzin temu
FDA Issues CRL for Epidermolysis Bullosa Gene Therapy
Drug Topics
The FDA has issued a complete response letter (CRL) to a biologics license application (BLA) for prademagene zamikeracel (pz-cel) because...
3 dni temu
FDA Decision Tracker: Pfizer’s First Gene Therapy Approved for Hemophilia B
BioSpace
In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA's...
8 godzin temu
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
Contemporary Pediatrics
As reported by sister publication CGTLive Monday night, the US Food and Drug Administration (FDA) issued a complete response letter (CRL) to...
3 dni temu
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel
Fierce Pharma
The FDA has rejected Abeona Therapeutics' gene therapy pz-cel, specifying chemistry, manufacturing and controls (CMC) issues that must be...
3 dni temu
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect
Zacks Investment Research
Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues,...
2 dni temu
Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost (NASDAQ:ABEO)
Seeking Alpha
Abeona Therapeutics stock dropped by over half after receiving a CRL from FDA regarding its BLA for pz-cel. Find out why ABEO stock is a...
3 dni temu
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for ...
GlobeNewswire
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP (www.johnsonfistel.com), a shareholder rights law firm, announces its...
3 dni temu
Here's Why You Should Retain Charles River (CRL) Stock Now
Yahoo Finance
Charles River Laboratories International, Inc. CRL is well-poised to grow in the coming quarters, backed by the strong growth of the RMS...
tydzień temu
CRL cuts Abeona market cap in half
The Pharma Letter
US biopharma Abeona Therapeutics was trading nearly 50% lower in Tuesday morning's trading after announcing a regulatory update for...
3 dni temu